Fingertip Sweat Patch for Parkinson's Levodopa Monitoring

Researchers at the University of California San Diego developed a battery-free, soft fingertip patch that continuously measures levodopa medication levels in sweat for Parkinson's disease patients. Published on August 7, 2026, in the Proceedings of the National Academy of Sciences, the wearable device provides readings comparable to standard laboratory blood tests while allowing patients to monitor treatment at home. The author highlights how the technology addresses the challenge of a shrinking therapeutic window in advanced Parkinson's disease, where medication effects fade abruptly. By replacing subjective patient diaries with real-time continuous sweat analysis, the patch helps prevent dangerous gaps between doses and severe involuntary jerking caused by over-medication. The device operates without an external battery by utilizing an absorbent hydrogel that draws sweat from the fingertips, which contain high concentrations of sweat glands. Embedded enzymes react with levodopa to generate a small voltage that simultaneously powers the device and estimates the drug concentration based on signal strength. Clinical testing demonstrated that Parkinson's patients metabolize and eliminate levodopa significantly faster than healthy individuals, explaining rapid symptom return. Future developments aim to integrate this patch into a closed-loop system communicating with an automatic medication delivery pump.